Breaking News Instant updates and real-time market news.

ACIU

AC Immune

$4.55 /

-0.41 (-8.27%)

, LLY

Eli Lilly

$122.57 /

-10.45 (-7.86%)

07:14
03/23/20
03/23
07:14
03/23/20
07:14

AC Immune receives second milestone in Lilly Morphomer Tau partnership

AC Immune (ACIU) announced that it will receive a second milestone payment of CHF10M from Eli Lilly and Company (LLY) on or before March 31, 2020 related to development progress in the small molecule Morphomer Tau aggregation inhibitor program. The multi-year collaboration agreement between Lilly and AC Immune was originally announced in December 2018 and focuses on the broad development of Morphomer Tau aggregation inhibitors for Alzheimer's disease and other neurodegenerative diseases. The second milestone payment of CHF10M marks significant progress between the companies in just 15 months. In that time, ACI-3024, a first-in-class investigational oral small molecule Tau Morphomer for treatment of Alzheimer's disease and other neurodegenerative disorders, has advanced from preclinical into Phase 1 clinical development. Lilly made a first milestone payment of CHF30M in September 2019. Under the updated collaboration terms, AC Immune will now also be eligible for a new CHF60M potential milestone after initiation of Tau Morphomer Phase 2 clinical testing. No additional changes were made to other later-stage milestones or royalty terms. Tau is a high priority therapeutic target in the complex treatment paradigm for AD and ACI-3024 is the most advanced orally available small molecule therapeutic candidate of its kind in development. ACI-3024's proposed unique mechanism of action targets both intracellular and extracellular Tau aggregates, potentially slowing or stopping the accumulation and propagation of pathological Tau aggregates in AD patients. Compared to other Tau-targeting molecules in development, the key potential differentiating factor is that ACI-3024 has been shown to act intracellularly to address specifically Tau pathology at an early stage. ACI-3024 is the lead molecule, discovered by AC Immune and being developed within the license and collaboration agreement between AC Immune and Lilly to research and develop small molecule Tau Morphomer aggregation inhibitors for the treatment of AD and other neurodegenerative diseases. The collaboration combines AC Immune's proprietary Morphomer discovery platform technology and early development experience with Lilly's established clinical development expertise and commercial capabilities in central nervous system disorders. Under the agreement AC Immune is conducting the initial Phase 1 development of ACI-3024 while Lilly will fund and conduct further clinical development. The Phase 1 trial initiated in July 2019 is a randomized, placebo-controlled, double-blind, sequential single and multiple ascending dose study that aims to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of ACI-3024 in healthy volunteers. Data from the study may be communicated as soon as the second half of 2020, at the discretion of Lilly.

ACIU

AC Immune

$4.55 /

-0.41 (-8.27%)

LLY

Eli Lilly

$122.57 /

-10.45 (-7.86%)

  • 30

    Mar

  • 06

    Apr

  • 23

    Apr

ACIU AC Immune
$4.55 /

-0.41 (-8.27%)

12/10/19 H.C. Wainwright
AC Immune price target raised to $11 from $8 at H.C. Wainwright
LLY Eli Lilly
$122.57 /

-10.45 (-7.86%)

03/11/20
Fly Intel: Top five analyst upgrades
03/11/20 Goldman Sachs
Eli Lilly upgraded to Conviction Buy from Buy at Goldman Sachs
03/09/20 Oppenheimer
Amgen price target lowered to $250 from $256 at Oppenheimer
02/27/20 Barclays
Eli Lilly initiated with an Overweight at Barclays

TODAY'S FREE FLY STORIES

General news
FX Action: The Canadian dollar has remained under pressure » 03:50
04/01/20
04/01
03:50
04/01/20
03:50

FX Action: The Canadian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FX Update: Commodity currencies have come under pressure » 03:25
04/01/20
04/01
03:25
04/01/20
03:25

FX Update: Commodity…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Asian Market Update: » 01:55
04/01/20
04/01
01:55
04/01/20
01:55

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
China's Caixin manufacturing PMI climbed 9.8 points to 50.1 in March » 01:15
04/01/20
04/01
01:15
04/01/20
01:15

China's Caixin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Avaya Cloud launch is significant opportunity for RingCentral, says Jefferies » 21:06
03/31/20
03/31
21:06
03/31/20
21:06
RNG

RingCentral

$211.53 /

-16.95 (-7.42%)

, AVYA

Avaya

$8.10 /

-0.595 (-6.84%)

Jefferies analyst Samad…

Jefferies analyst Samad Samana keeps a Buy rating on RingCentral (RNG) shares with a price target of $245, saying the launch of Avaya (AVYA) Cloud Office, or ACO, by RingCentral is a "significant opportunity" for the company that will drive strong growth for years to come. The analyst notes that ACO enables voice calls, team messaging, meetings, conferencing, and file sharing, adding that the deal should also accelerate RingCentral's move internationally as well as upmarket. Samana further notes that because of COVID-19 however, it may take until 2021 before ACO makes any material financial impact on RingCentral.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
SPDR Gold Shares holdings rise to 967.00MT from 964.36MT » 20:21
03/31/20
03/31
20:21
03/31/20
20:21
GLD

SPDR Gold Shares

$148.19 /

-4.71 (-3.08%)

This is the highest level…

This is the highest level of holdings since October of 2016.

Syndicate
SG Blocks announces automatic common stock offering » 20:12
03/31/20
03/31
20:12
03/31/20
20:12
SGBX

SG Blocks

$9.07 /

+7.055 (+351.00%)

ThinkEquity, a division…

ThinkEquity, a division of Fordham Financial Management, Inc., is acting as representative of the underwriters in the offering.

Hot Stocks
Daiichi Sankyo, Ultragenyx enter gene therapy manufacturing partnership » 20:02
03/31/20
03/31
20:02
03/31/20
20:02
RARE

Ultragenyx

$44.46 /

+0.125 (+0.28%)

, DSNKY

Daiichi Sankyo

$0.00 /

+ (+0.00%)

Ultragenyx (RARE)…

Ultragenyx (RARE) announced a strategic partnership and non-exclusive license and technology access agreement with Daiichi Sankyo (DSNKY) for Ultragenyx's proprietary AAV-based gene therapy manufacturing technologies. Ultragenyx's HeLa producer cell line platform enables large commercial-scale AAV-based gene therapy product manufacturing that is intended to be highly reproducible, more consistent, and less expensive than other gene therapy manufacturing platforms. In addition, Ultragenyx has developed a proprietary HEK293 transient transfection system for AAV manufacture which is also a subject of the collaboration. Under the license and technology access agreement, Ultragenyx granted Daiichi Sankyo a non-exclusive license to intellectual property, including know-how and patent applications, with respect to its HeLa PCL and HEK293 transient transfection manufacturing technology platforms for AAV-based gene therapy products. The parties will collaborate closely as part of a technology transfer plan to enable Daiichi Sankyo to use the technologies for its internal gene therapy programs. Ultragenyx retains the exclusive right to use its manufacturing technology for its current target indications and additional indications identified now and in the future. Under the terms of the agreements, Daiichi Sankyo will make an upfront payment of $125M and will purchase $75M of Ultragenyx common stock at a price of approximately $60 per share. Daiichi Sankyo will pay an additional $25M upon completion of the technology transfer of the HeLa PCL and HEK293 platforms as well as single-digit royalties on net sales of products manufactured in either system. Daiichi Sankyo will reimburse Ultragenyx for all costs associated with the transfer of the manufacturing technology.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Nidec to acquire the Delta production line from Secop Austria » 19:42
03/31/20
03/31
19:42
03/31/20
19:42
NJDCY

Nidec

$0.00 /

+ (+0.00%)

Nidec announced that the…

Nidec announced that the company has signed a definitive agreement with Secop Austria GmbH on March 31, 2020, by which Nidec will acquire the Delta production line from Secop through the Company's sub-subsidiary Nidec Global Appliance Italy S.r.l. and its Austrian company. With this transaction, Nidec and Secop aim to preserve as many jobs as possible at the site in Furstenfeld, Austria. Nidec will take over approximately 40 employees for the production of household refrigeration compressors on the Delta line and has already retained 47 employees for the production of motors for washing machines and dish washers. Furthermore, Secop will retain and strengthen its group headquarter in the Furstenfeld area and therefore retain in excess of 80 employees. As a result, more than 170 of the current 300 jobs at the Furstenfeld site will be saved.

Recommendations
Aveo Pharmaceuticals price target lowered to $18.50 from $20 at Piper Sandler » 19:19
03/31/20
03/31
19:19
03/31/20
19:19
AVEO

Aveo Pharmaceuticals

$3.58 /

-0.02 (-0.56%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff lowered the firm's price target on Aveo Pharmaceuticals to $18.50 from $20 and keeps an Overweight rating on the shares after the company submitted its NDA for tivozanib in third-line renal cell carcinoma on the basis of positive TIVO-3 data. Tenthoff said he believes the TIVO-3 OS hazard ratio will remain below 1.0 due to the fact that more patients remian on tivo than Nexavar.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Fly Intel: After-Hours Movers » 18:54
03/31/20
03/31
18:54
03/31/20
18:54
AVEO

Aveo Pharmaceuticals

$3.58 /

-0.02 (-0.56%)

, OII

Oceaneering

$2.90 /

-0.55 (-15.94%)

, VECO

Veeco

$9.57 /

-0.39 (-3.92%)

, VRNT

Verint

$42.73 /

-0.04 (-0.09%)

, BB

BlackBerry

$4.10 /

+0.185 (+4.73%)

, HPQ

HP Inc.

$17.38 /

-0.46 (-2.58%)

, XRX

Xerox

$18.88 /

+0.91 (+5.06%)

, BRKR

Bruker

$35.88 /

-2.67 (-6.93%)

, ATI

Allegheny Technologies

$8.48 /

-0.25 (-2.86%)

, GIII

G-III Apparel

$7.70 /

+0.49 (+6.80%)

HIGHER -• Aveo Pharma…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Disney to launch streaming service in India on April 3, Bloomberg reports » 18:45
03/31/20
03/31
18:45
03/31/20
18:45
DIS

Disney

$96.54 /

-3.3 (-3.31%)

Disney will launch its…

Disney will launch its streaming service in India later this week, after a coronavirus lockdown thwarted its previous plans, Bloomberg's P R Sanjai and Ragini Saxena report. The company planned to kick off Disney+ in India at the start of the wildly popular Indian Premier League cricket season on March 29. That event has been postponed for two weeks due to the pandemic. Disney said the service will now launch on April 3. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Conagra Brands CEO: We're selling everything we can make » 18:40
03/31/20
03/31
18:40
03/31/20
18:40
CAG

Conagra Brands

$29.28 /

+0.93 (+3.28%)

In an interview on…

In an interview on CNBC's Mad Money, Conagra Brands CEO Sean Connolly said the company was "running flat out" to keep its food coming. "We've had no disruptions at our plants. Consumers are eating everything at home so we're selling everything," Connolly added. He said the company's frozen and snacks businesses are both growing rapidly. He noted, "We have so much confidence in the frozen business. That's one of the reasons we bought Pinnacle." Connolly said the company's online business "is exploding" and gaining market share.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Sally Beauty appoints Mario Cormier as Finance and Chief Accounting Officer » 18:35
03/31/20
03/31
18:35
03/31/20
18:35
SBH

Sally Beauty

$8.05 /

-0.74 (-8.42%)

Sally Beauty Holdings…

Sally Beauty Holdings announced the appointment of Marlo Cormier, as Senior Vice President - Finance and Chief Accounting Officer. Cormier was also named to the Company's senior leadership team. Cormier joins the Company from Fossil Group, where she was Senior Vice President, Corporate Finance and Chief Accounting Officer. At Fossil Group, Ms. Cormier's responsibilities included general accounting and SEC reporting, financial planning and analysis, taxes and treasury. Prior to her role at Fossil Group, Cormier was the Vice President and Chief Accounting Officer of Callaway Golf and a Manager in Deloitte's Accounting and Audit Services group.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
CVB Financial suspends stock repurchase plan under 10b5-1 program » 18:29
03/31/20
03/31
18:29
03/31/20
18:29
CVBF

CVB Financial

$20.05 /

-0.04 (-0.20%)

CVB Financial announced…

CVB Financial announced that it will suspend its 10b5-1 stock repurchase program. The company's Board of Directors previously authorized the company to repurchase up to 9.6M shares of the company's common stock.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Palo Alto Networks CEO: Committed to no layoffs amid COVID-19 pandemic » 18:26
03/31/20
03/31
18:26
03/31/20
18:26
PANW

Palo Alto Networks

$163.87 /

-3.21 (-1.92%)

In an interview on…

In an interview on CNBC's Mad Money, Palo Alto Networks CEO Nikesh Arora said they were one of the first companies to send employees home during the COVID-19 pandemic. He added that Palo Alto is committed to no layoffs during this time. "We are choosing to balance people over profit in the short term," Arora said. He added, "The execution is back, full on. It should result in a good outcome for the company."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Apple says will pay contract workers during shelter-in-place, SVBJ says » 18:13
03/31/20
03/31
18:13
03/31/20
18:13
AAPL

Apple

$254.28 /

-0.61 (-0.24%)

Apple said it plans to…

Apple said it plans to pay contract workers who were sent home during the coronavirus shelter-in-place, the Silicon Valley Business Journal's Allison Levitsky reports. The company originally had not committed to paying such contract workers, Levitsky notes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Caterpillar says will not provide annual salary bumps this year, Reuters reports » 17:57
03/31/20
03/31
17:57
03/31/20
17:57
CAT

Caterpillar

$116.12 /

+4.5 (+4.03%)

Caterpillar said it will…

Caterpillar said it will not give out annual salary raises this year as part of a cost cut plan to grapple with the economic fallout from the COVID-19 outbreak, Reuters reports. The company added that it will not pay out bonuses to eligible employees next year, the report says. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Johnson & Johnson to hold 2020 Annual Meeting of Shareholders in virtual format » 17:56
03/31/20
03/31
17:56
03/31/20
17:56
JNJ

Johnson & Johnson

$131.08 /

-2.02 (-1.52%)

Johnson & Johnson…

Johnson & Johnson announced that the 2020 Annual Meeting of Shareholders will now be conducted exclusively online by remote communication. This decision was made in light of the coronavirus outbreak, public health concerns, the current state of emergency in New Jersey and government-recommended and required limits on public gatherings and to assist in protecting the health and safety of the company's shareholders and employees. The meeting will be held at 10:00 a.m. Eastern Time on April 23, and will be conducted in a virtual format only. Shareholders will not be able to attend the 2020 annual meeting in person, however shareholders of record as of the close of business on February 25 will be able vote and ask questions during the meeting through the online platform.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Treasury announced several cash management bills (CMBs) for the rest of this week » 17:55
03/31/20
03/31
17:55
03/31/20
17:55

Treasury announced…

Treasury announced several cash management bills (CMBs) for the rest of this week. These include a $40 B 119-day CMB and a $45 B 39-day CMB for sale Wednesday. There's also a $40 B 154-day CMB set for Thursday. This follows the two CMB auctions Tuesday, totaling $105 B. Additionally, the debt managers have continued boosting the volume of the weekly bill offerings. Officials announced a $30 B increase to the upcoming 4- and 8-week bill auctions to $140 B, up from $110 B last week, with an $80 B 4-week (versus $60 B last week) and a $60 B 8-week (versus $50 B last week).

Hot Stocks
Equinox Gold sees FY20 production of 540,00-600,000 ounces of gold » 17:52
03/31/20
03/31
17:52
03/31/20
17:52
EQX

Equinox Gold

$6.60 /

+0.12 (+1.85%)

Equinox Gold announces…

Equinox Gold announces 2020 production and cost guidance of 540,000 to 600,000 ounces of gold at all-in-sustaining costs, or AISC, of $1,000 to $1,060 per oz. Guidance for the Los Filos, Fazenda, RDM and Pilar mines reflects production expectations from March 10 the closing date of the merger with Leagold Mining, to December 31. Total consolidated 2020 production, including gold produced by Leagold in 2020 before completion of the merger, is estimated at 615,000 to 680,000 oz of gold. "Equinox Gold had another year of tremendous growth in 2019. The Company advanced its Aurizona mine to production, commenced construction at its Castle Mountain mine and ended 2019 with the announcement of a merger with Leagold to create a premier gold producer with exceptional growth potential," said the company. "With the merger complete, Equinox Gold expects to more than triple its annualized gold production in 2020 and is fully funded to increase production over the next two years to more than one million ounces of gold annually. We also recognize the challenges presented by the COVID-19 pandemic and its potential effect on our operations and our guidance for this year. If necessary, we will adjust our expectations as the situation evolves."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
HP Inc. says remains 'firmly committed' to driving value for shareholders » 17:49
03/31/20
03/31
17:49
03/31/20
17:49
HPQ

HP Inc.

$17.38 /

-0.46 (-2.58%)

, XRX

Xerox

$18.88 /

+0.91 (+5.06%)

HP Inc. (HPQ) issued the…

HP Inc. (HPQ) issued the following statement following Xerox Holding Corporation's (XRX) withdrawal of its unsolicited exchange offer and director nominations: "We remain firmly committed to driving value for HP shareholders. HP is a strong company with market leading positions across Personal Systems, Print, and 3D Printing & Digital Manufacturing. We have a healthy cash position and balance sheet that enable us to navigate unanticipated challenges such as the global pandemic now before us, while preserving strategic optionality for the future. Our focus remains on addressing the needs of our ecosystem of stakeholders around the world, ensuring that we build on our strength and resiliency throughout this crisis and position the business for the opportunities ahead. HP would like to thank our shareholders, partners, customers and employees for their input and continued support through this process."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
RPT Realty takes measures to strengthen liquidity, balance sheet flexibility » 17:44
03/31/20
03/31
17:44
03/31/20
17:44
RPT

RPT Realty

$6.02 /

+0.26 (+4.51%)

RPT Realty issued the…

RPT Realty issued the following statement regarding the COVID-19 pandemic and announced that it has taken decisive actions to enhance liquidity and balance sheet flexibility in light of the potential impact of the pandemic on the company's business. The company has taken the following measures to further strengthen liquidity and increase balance sheet flexibility: Drew down $225M on its previously unused revolving line of credit in March 2020. Suspended all acquisition and disposition activity until further notice with no transactions made since December 31, 2019. Suspended all new development and redevelopment project starts until further notice and currently have no committed development or redevelopment projects in progress. Started deferring all but essential maintenance capital expenditures in early March. The board is evaluating the company's dividend policy with decisions regarding future dividend payments beyond the previously announced Q1 dividend, payable on April 1, to be made based on then current market and business conditions. Decisions regarding future dividends will be made with liquidity, capital preservation and sustainability as the company's highest priorities, while still meeting REIT qualification requirements. Following the $225M drawdown on the revolving line of credit the company had approximately $320M of cash and cash equivalents representing approximately 2x its 2019 base rent.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
S&P announces changes to S&P 100, 500, 600 indices » 17:41
03/31/20
03/31
17:41
03/31/20
17:41
UTX

United Technologies

$94.27 /

-4.22 (-4.28%)

, OTIS

Otis Worldwide

$0.00 /

+ (+0.00%)

, CARR

Carrier Global

$0.00 /

+ (+0.00%)

, RTN

Raytheon

$131.28 /

-9.76 (-6.92%)

, M

Macy's

$4.90 /

-0.465 (-8.67%)

, AMT

American Tower

$217.26 /

-13.115 (-5.69%)

, KLXE

KLX Energy

$0.70 /

+0.0113 (+1.64%)

United Technologies (UTX)…

United Technologies (UTX) is spinning off Otis Worldwide and Carrier Global and then merging with Raytheon in transactions expected to be completed on April 3. Post spin-off and merger transactions, United Technologies will remain in the S&P 500 & 100 indices. It will change its name to Raytheon Technologies and its ticker symbol to "RTX." Otis Worldwide (OTIS) and Carrier Global (CARR) will be added to the S&P 500 prior to the open of trading on Friday, April 3. Otis Worldwide will replace Raytheon (RTN), and Carrier Global will replace Macy's (M) both of which will be removed from the S&P 500 effective prior to the open of trading on Monday, April 6. Also effective on April 6, American Tower (AMT) will replace Raytheon in the S&P 100, and Macy's will replace KLX Energy Services Holdings (KLXE) in the S&P SmallCap 600. Macy's has a market capitalization more representative of the small-cap market space. KLX Energy is no longer representative of the small-cap market space.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
RPT Realty withdraws FY20 guidance » 17:41
03/31/20
03/31
17:41
03/31/20
17:41
RPT

RPT Realty

$6.02 /

+0.26 (+4.51%)

Given the uncertainties…

Given the uncertainties surrounding the impact of the COVID-19 pandemic on the economy, the company is withdrawing all previously provided guidance for FY20 as disclosed in the company's Q4 2019 earnings press release.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.